Salvage treatment with apatinib for advanced non-small-cell lung cancer

机译：阿帕替尼对晚期非小细胞肺癌的挽救治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveNo definitive chemotherapeutic regimen has been established in patients with non-small-cell lung cancer (NSCLC) who failed second- or third-line treatment. The aim of this study was to evaluate apatinib, a VEGFR-2 inhibitor, in advanced NSCLC as salvage treatment.

机译：目的尚未建立针对二线或三线治疗失败的非小细胞肺癌（NSCLC）患者的明确化疗方案。这项研究的目的是评估一种VEGFR-2抑制剂阿帕替尼在晚期NSCLC中的挽救治疗。

著录项

期刊名称 OncoTargets and therapy
作者
Zhengbo Song; Xinmin Yu; Guangyuan Lou; Xun Shi; Yiping Zhang;
展开▼
作者单位

展开▼
年(卷),期 2017(10),-1
年度 2017
页码 1821–1825
总页数 5
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
non-small-cell lung cancer apatinib VEGF efficacy;

机译：非小细胞肺癌;阿帕替尼;VEGF;疗效;

相似文献

外文文献
中文文献
专利

1. Salvage treatment with apatinib for advanced non-small-cell lung cancer [J] . Zhengbo Song, Xinmin Yu, Guangyuan Lou, OncoTargets and therapy . 2017,第6期

机译：阿帕替尼对晚期非小细胞肺癌的挽救治疗
2. Apatinib Alone or Combined with Radiation Therapy As a Salvage Treatment in Advanced Non-Small Cell Lung Cancer Failed from Two or More Lines of Prior Chemotherapy or Molecular Targeted Therapy [J] . Li T., Lv J., Wang Q., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：单独的Apatinib或与放射治疗结合作为晚期非小细胞肺癌的救人治疗失败，从两种或更多种以前化学疗法或分子靶向治疗
3. P2.01-017 Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer [J] . Z. Xu, C. Xu, W. Wang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P2.01-017先进非小细胞肺癌磷酸盐损伤治疗的研究
4. Effects of Erlotinib after Acquired Resistance to Gefitinib in Advanced Non-small-cell Lung Cancer [C] . Pan Jingjing, Shi Meiqi, Feng Jifeng Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on . 2012

机译：吉非替尼耐药对晚期非小细胞肺癌患者的厄洛替尼治疗效果
5. The Effectiveness of EGFR-TKIs in Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis. [D] . Li, Xiao. 2016

机译：EGFR-TKIs在非小细胞肺癌治疗中的有效性：一项荟萃分析。
6. Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer [O] . Jiao Leng, Dai-Rong Li, Lu-Mi Huang, -1

机译：阿帕替尼作为晚期转移性非小细胞肺癌的三线治疗和更多治疗有效
7. Salvage treatment with apatinib for advanced non-small-cell lung cancer [O] . Zhengbo Song, Xinmin Yu, Guangyuan Lou, 2017

机译：用Apatinib进行抢救治疗前期非小细胞肺癌

Salvage treatment with apatinib for advanced non-small-cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅